LIMITATIONS OF CLASSICAL IN VITRO MODELS FOR ASSESSING THE HYPOCHOLESTEROLEMIC ACTIVITY OF LACTIC ACID BACTERIA
Ключові слова:
probiotics, cholesterol, BSH activity, intestinal microbiota.Анотація
These theses are devoted to the analysis of the limitations of classical in vitro models used to assess the hypocholesterolemic activity of probiotic LAB. Particular attention is given to discrepancies between in vitro and in vivo results, which arise from the incomplete consideration of cholesterol-lowering mechanisms, interactions with the intestinal microbiota, and methodological limitations.
Посилання
Schade D. S., Shey L., Eaton R. P. Cholesterol review: a metabolically important molecule. Endocrine Practice. 2020. Vol. 26, no. 12. P. 1514–1523. URL: https://doi.org/10.4158/ep-2020-0347.
Primary hypercholesterolemia and development of cardiovascular disorders: Cellular and molecular mechanisms involved in low-grade systemic inflammation and endothelial dysfunction / A. Collado et al. The International Journal of Biochemistry & Cell Biology. 2021. Vol. 139. P. 106066. URL: https://doi.org/10.1016/j.biocel.2021.106066.
Hypolipidemic activity of lactic acid bacteria: Adjunct therapy for potential probiotics / S. M. Ali et al. PLOS ONE. 2022. Vol. 17, no. 6. P. e0269953. URL: https://doi.org/10.1371/journal.pone.0269953.
The probiotic properties of Lactiplantibacillus plantarum isolated from plant material / D. S. Holubchyk et al. Biotechnologia Acta. 2025. Vol. 18, no. 1. P. 38–43. URL: https://doi.org/10.15407/biotech18.01.038.
Unlocking the potential of probiotics: a comprehensive review on research, production, and regulation of probiotics / T. F. da Silva et al. Probiotics and Antimicrobial Proteins. 2024. URL: https://doi.org/10.1007/s12602-024-10247-x.
How much in vitro cholesterol reducing activity of lactobacilli predicts their in vivo cholesterol function? / G. Madani et al. Int J Prev Med. 2013. Vol. 4, no. 4. P. 404–13.
In vitro characterization of lactic acid bacteria from indonesian kefir grains as probiotics with cholesterol-lowering effect / D. Yusuf et al. Journal of Microbiology and Biotechnology. 2020. Vol. 30, no. 5. P. 726–732. URL: https://doi.org/10.4014/jmb.1910.10028.
Screening for cholesterol-lowering probiotics from lactic acid bacteria isolated from corn silage based on three hypothesized pathways / C. Ma et al. International Journal of Molecular Sciences. 2019. Vol. 20, no. 9. P. 2073. URL: https://doi.org/10.3390/ijms20092073.
Effects of an exopolysaccharide (kefiran) on lipids, blood pressure, blood glucose, and constipation / H. Maeda et al. BioFactors. 2004. Vol. 22, no. 1-4. P. 197–200. URL: https://doi.org/10.1002/biof.5520220141.
Screening and Characterization of Some Lactobacillaceae for Detection of Cholesterol-Lowering Activities / M. Frappier et al. Probiotics and Antimicrobial Proteins. 2022. URL: https://doi.org/10.1007/s12602-022-09959-9.
Cholesterol lowering in diet-induced hypercholesterolemic mice using lactobacillus bile salt hydrolases with different substrate specificities / M. Zhao et al. Food & Function. 2023. URL: https://doi.org/10.1039/d3fo04871c.
Upregulation of taurine biosynthesis and bile acid conjugation with taurine through fxr in a mouse model with human-like bile acid composition / T. Miyazaki et al. Metabolites. 2023. Vol. 13, no. 7. P. 824. URL: https://doi.org/10.3390/metabo13070824.
Cholesterol-lowering mechanism of lactobacillus bile salt hydrolase through regulation of Bifidobacterium pseudolongum in the gut microbiota / Y. Liu et al. Nutrients. 2025. Vol. 17, no. 18. P. 3019. URL: https://doi.org/10.3390/nu17183019.
Ichim T. E., Patel A. N., Shafer K. A. Experimental support for the effects of a probiotic/digestive enzyme supplement on serum cholesterol concentrations and the intestinal microbiome. Journal of Translational Medicine. 2016. Vol. 14, no. 1. URL: https://doi.org/10.1186/s12967-016-0945-2.
Fermented dairy product consumption and blood lipid levels in healthy adults: a systematic review / B. Yilmaz et al. Frontiers in Nutrition. 2025. Vol. 12. URL: https://doi.org/10.3389/fnut.2025.1651134.
Bhat B., Bajaj B. K. Multifarious cholesterol lowering potential of lactic acid bacteria equipped with desired probiotic functional attributes. 3 Biotech. 2020. Vol. 10, no. 5. URL: https://doi.org/10.1007/s13205-020-02183-8.
Cholesterol-lowering potentials of lactic acid bacteria based on bile-salt hydrolase activity and effect of potent strains on cholesterol metabolism in vitro and in vivo / C.-C. Tsai et al. The Scientific World Journal. 2014. Vol. 2014. P. 1–10. URL: https://doi.org/10.1155/2014/690752.
In vitro assessment of pediococci- and lactobacilli-induced cholesterol-lowering effect using digitally enhanced high-performance thin-layer chromatography and confocal microscopy / R. N. Syakila et al. Analytical and Bioanalytical Chemistry. 2019. Vol. 411, no. 6. P. 1181–1192. URL: https://doi.org/10.1007/s00216-018-1544-2.
Kolarič L., Šimko P. The comparison of HPLC and spectrophotometric method for cholesterol determination. Potravinarstvo Slovak Journal of Food Sciences. 2020. Vol. 14. P. 118–124. URL: https://doi.org/10.5219/1302.
